Bedfont® Scientific Limited Concludes the Shaun in the Heart of Kent Trail by Presenting a CELLER8® Device to a Successful Participant

The Shaun in the Heart of Kent art trail, sponsored by Bedfont®, unites the community while supporting Heart of Kent Hospice and promoting health with CELLER8®.

Muvalaplin shows promise in lowering Lp(a) levels in clinical trial

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science

November 20, 2024

Mursla Bio joins leading European consortium to advance clinical applications based on extracellular vesicle science

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic

November 12, 2024

HI-Bio dishes on motivations for Biogen buyout, citing desire to move fast

Why did Human Immunology Biosciences get bought out less than five months after closing a $95 million Series B? HI-Bio’s executives were highly confident in

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.